Market Overview:

The global vital signs monitoring devices market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2027, exhibiting a growth rate (CAGR) of 6.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Vital signs monitoring devices refer to various medical equipment used for monitoring a patient's vital signs. This includes blood pressure monitoring devices, pulse oximeters and temperature monitoring devices that are used for observing various vital signs, such as blood pressure, body temperature, pulse rate and respiratory rate. These devices are portable, small-sized, reliable and can be set up in a medical setting, residential complexes and at the site of a medical emergency. They can also be used for monitoring activity and fitness levels for self-health tracking and early diagnosis of medical ailments.

The increasing prevalence of chronic and lifestyle-associated medical ailments across the globe is one of the key factors driving the growth of the market. Furthermore, growing geriatric population and increasing awareness regarding home monitoring devices are also providing a boost to the market growth. As at-home vital signs monitoring devices are cost-effective, easy-to-use and can measure various physiological parameters of the body using multi-parameter patient monitors, it is contributing to their rising demand. Apart from this, the onset of COVID-19 (coronavirus disease) has led to a significant increase in the demand of these devices to determine the patient’s health status, provide them with appropriate care and predict recovery. Additionally, various technological advancements, such as the integration of health monitoring devices with bluetooth, sensors and micro-electric technologies, are also creating a positive outlook for the market. Other factors, including improvements in the healthcare infrastructure and the increasing adoption of wearable healthcare devices, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global vital signs monitoring devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and end-user.

Breakup by Product Type:

• BP Monitoring Devices
  • Aneroid BP Monitors
  • Automated BP Monitors
• Pulse-Oximeters
  • Tabletop/Bedside Pulse-Oximeters
  • Fingertip
  • Handheld
  • Wrist Worn
  • Pediatric Pulse-Oximeters
• Temperature Monitoring Devices
  • Mercury-Filled Thermometers
  • Digital Thermometers
  • Infrared Thermometers
  • Temperature Strips
• Others
   

Breakup by End-User:

• Hospitals and Clinics
• Ambulatory Surgery Centers (ASCs)
• Home Care
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being A&D Company Ltd., Contec Medical Systems Co. Ltd., GE Healthcare, Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Nonin Medical Inc., Omron Healthcare Inc., Smiths Group Plc, etc.

Report Coverage: